Health Care

Did EpiPen maker Mylan cheat taxpayers out of $1.27B?

Drug maker Mylan (NASDAQ:MYL), which manufactures the allergy treatment EpiPen, found itself at the center of yet another controversy Wednesday, after the Department of Health and Human Services said the government may have overpaid the company by $1.27 billion from 2006-2016.

How major US stock market indexes fared on Wednesday

U.S. stock indexes edged lower for the second day in a row Wednesday as a sharp drop for banks and a rare loss for technology companies canceled out gains for drugmakers and consumer-focused companies.

Health records vendor settles false claims suit for $155M

Federal prosecutors say one of the country's largest vendors of electronic health records will pay a $155 million settlement to resolve allegations that it caused health care providers to submit false claims to the U.S. Department of Health and Human Services.

Fiat Chrysler Recalls 1M Ram Pickup Trucks

Fiat Chrysler is recalling about 1 million Ram pickup trucks that have faulty software potentially keeping safety features from working properly during a rollover.

VA Secretary Shulkin: Fixing wait times remain top priority

The Department of Veterans Affairs (VA) has come under scrutiny for a number of scandals, including the revelation in 2014 that an increase in wait times at the Phoenix VA contributed to the deaths of at least 40 military heroes.

Governor to decide whether to force insulin price disclosure

The fate of a bill to force pharmaceutical companies to disclose insulin data, register sales representatives and ultimately divulge their funding of patient organizations rested with Republican Gov. Brian Sandoval on Thursday.